Improving physiological relevance in neurological disease drug development
Drug Discovery World
JUNE 27, 2024
The interview highlights their need to develop assays that are amenable to long term use to support their clients with drug development, and how bit.bio’s deterministically programmed ioMicroglia have helped them develop assays with increased physiological relevance and consistency, towards this goal.
Let's personalize your content